Medical News
Latest News on Primary Aldosteronism
- Medical Report: All high blood pressure is not the same October 2, 2023When it comes to high blood pressure, most people have what is called essential hypertension or primary hypertension. In these cases, high blood pressure is often due to an unhealthy diet, family history or obesity.audacy
- Diagnosis Helps Resolve Marlboro Woman’s Hypertension - Hellenic News of America September 26, 2023"I was taking all these medications, but nothing was happening. I was feeling all the symptoms" Kitty Chow explainsHellenic News of America
- Setting PACE - Primary Aldosteronism research boost September 26, 2023A hidden cause of disease for more than half a million Australians - and the researchers pioneering its detection and treatment - have been recognisedMirage News
- MNHS researchers awarded $7.5million in NHMRC Centres of Research Exce September 26, 2023The Federal Government has today announced $7.5 million in funding for three National Health and Medical Research Council (NHMRC) Centres for Research Excellence led by Monash Medicine Nursing and Allied Health researchers.Medicine, Nursing and Health Sciences
- $35M Allocated for New Health Research Centers September 25, 2023NHMRC welcomes the Australian Government's announcement of outcomes from the 2023 Centres of Research Excellence (CRE) scheme. Fourteen new Centres ofMirage News
- Sjogren’s Syndrome Complicated With Aldosterone-Producing Adenoma: A Case Report September 22, 2023Hypokalemia may be present in some patients with Sjogren's syndrome. When a patient with Sjogren's syndrome presents with hypokalemia, we would first consider it to be a result of the renal invo...cureusinc
- Primary Aldosteronism Market Growth and Industry Insight 2023 to 2030 September 21, 2023Global Primary Aldosteronism Market Latest Research Report (2023-2031) is segmented into Regions, Applications(Hospitals and Clinics, Research Organization, Academic Institutes), and Types(Type I, Type II). The reportThe Express Wire
PA Foundation in the News
- Primary Aldosteronism AllianceIn September 2022, the PA Foundation announced the creation of a multistakeholder alliance to drive diagnosis and treatment of primary aldosteronism.
- Dietary Sodium Global Call to ActionThe PA Foundation is one of the co-authors of the World Hypertension League’s call to action published in May 2022 by the Journal of Human Hypertension.
BMJ Practice Series: Easily Missed?The PA Foundation co-authored the article of the BMJ Practice Series on primary aldosteronism. The open access article was published in April 2022.
Doctors Overlook a Curable Cause of High BPMIT’s magazine, Undark, featured the PA Foundation in an article of its February 2022 edition dedicated to primary aldosteronism.
Notable Publications of the Year
Renal Stones and PA
Patients with PA have a higher incidence rate of renal stones than the general population, and have larger and harder stones than essential hypertensives.
AVS in Patients with Contrast Allergy
Premedication with high dose dexamethasone to perform AVS is safe and accurate for diagnosing the source of aldosterone excess in patients with PA and allergy to iodine contrast media.
Confirmatory Tests Review and Meta-Analysis
Test conduct, interpretation and verification varied largely. Under most scenarios, testing resulted in an excess of missed cases. Certainty of evidence underlying each test was very low.
PA in Pregnancy
Fertile women with arterial hypertension should be screened for PA before pregnancy and, if necessary, subtyped to identify unilateral forms of PA.
Sedation on AVS without Corticotropin Stimulation
Midazolam and fentanyl can lead to a clinically significant reduction in cortisol concentration during unstimulated AVS, with lower selectivity indexes and fewer successful cannulations.
Latest News on Hypertension
- Why diabetes with hypertension is a dangerous mix: What should you do? October 4, 2023Like with diabetes, the challenge with hypertension is that most often it produces no symptoms till organ damage has occurred, says Dr Ambrish Mithal, Chairman of Endocrinology and Diabetes at Max HealthcareDr. Ambrish Mithal
- Global Blood Pressure Monitors Market Research Report 2023: A $3.1 Billion Market by 2031 - North America Dominates but Asia-Pacific Shows Rapid Growth October 3, 2023The "Global Blood Pressure Monitors Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering.PR Newswire
- Poor sleep may increase risk of hypertension in women: Study October 3, 2023Women who struggle with getting enough sleep may be at greater risk of developing hypertension, or high blood pressure, a new study has shown.The Tribune India
- Galectin Therapeutics Reports the Positive Outcome of the Fourth Data and Safety Monitoring Board Meeting for NAVIGATE, its Seamless, Adaptive Phase 2b/3 Study of Belapectin in Patients with Portal Hypertension Caused by Non-Alcoholic SteatoHepatitis Liver Cirrhosis October 3, 2023NORCROSS, Ga., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3, today reported the positive outcome of its fourth data and safety monitoring board (DSMB) meeting for NAVIGATE, its seamless, adaptive, Phase 2b/3 study of belapectin in patients with portal hypertension caused by non-alcoholic steatohepatitis […]Galectin Therapeutics Inc.
- Granules India gets USFDA approval for hypertension drug; share price gains October 3, 2023Losartan potassium and hydrochlorothiazide tablets are indicated for the treatment of hypertension to lower blood pressure and to reduce the risk of stroke in patients with hypertension and left ventricular hypertrophy.Moneycontrol News
- Global Blood Pressure Monitors Market Research Report 2023-2031 - Digital Innovation Revolutionizes Blood Pressure Monitoring for a Healthier Future October 3, 2023Dublin, Oct. 03, 2023 (GLOBE NEWSWIRE) -- TheResearch and Markets
